NovaBios-埃博拉病毒IgG抗体检测试剂盒

美国NovaBios埃博拉病毒IgG抗体检测试剂盒

广州健仑生物科技有限公司

本司长期供应埃博拉病毒检测试剂盒，其主要品牌包括美国NovaBios、广州创仑等CDC使用的进口产品，试剂盒的实验方法包括胶体金方法、ELISA方法、PCR方法等。

欢迎咨询

欢迎咨询2042552662

埃博拉病毒IgM、IgG、ELISA检测试剂、埃博拉快速检测试剂盒、

埃博拉病毒核酸检测试剂盒（荧光探针PCR）

西非工作、旅游埃博拉检测试剂盒

美国CDC使用的埃博拉诊断试剂——美国的NovaBios

美国NovaBios 埃博拉病毒IgG抗体检测试剂盒

【埃博拉简介】

埃博拉（Ebola virus）又译作伊波拉病毒。是一种十分罕见的病毒，1976年在苏丹南部和刚果（金）（旧称扎伊尔）的埃博拉河地区发现它的存在后，引起医学界的广泛关注和重视，“埃博拉”由此而得名。是一个用来称呼一群属于纤维病毒科埃博拉病毒属下数种病毒的通用术语。是一种能引起人类和灵长类动物产生埃博拉出血热的烈性传染病病毒，有很高的死亡率，在50%至90%之间，致死原因主要为中风、心肌梗塞、低血容量休克或多发性器官衰竭。

埃博拉出血热（EBHF）是由一种丝状病毒感染导致的急性出血性、动物源性传染病。1976年，埃博拉出血热在非洲的苏丹和扎伊尔暴发，病死率高达50% ～ 90% 。因该病始发于扎伊尔北部的埃博拉河流，并在该区域严重流行，故命名为埃博拉病毒，其形态学、致病性等与马尔堡病毒相似，但免疫原性有所区别。

【产品介绍】

该产品是世界卫生组织（WHO）*个批准用于埃博拉病毒检测的诊断试剂卡。不需要借助其他实验仪器设备，只需要采取几滴血清、血浆、血液样品，既可以检测，并在15分钟内就可以得知结果是否感染埃博拉病毒。该产品具有灵敏度高、操作方便、实验时间短等特点。

美国NovaBios 埃博拉病毒IgG抗体检测试剂盒

诊断和治疗：困难来自何方
　　由于埃博拉病毒发病初期和感冒等通常疾病比较类似，使得卫生当局极易发生误诊，耽搁了防疫措施的及时开展。
　　传统的诊断方式需要通过复杂的实验室试验（PCR 和 ELISA）来检查感染者体内是否存在抗原。的技术可以通过患者的吐沫和尿液来检查是否存在埃博拉病毒。确症埃博拉病毒需要相对较长时间，这进一步耽搁了防疫过程。这也就是为什么2013年12月就在几内亚爆发疫情，而到2014年3月才zui终确认了疫情。
　　到目前为止，科学家对埃博拉病毒的致病机理也不甚明了。大家普遍认为埃博拉病毒通过摧毁人体的免疫系统，阻止人体的适应性免疫系统发生作用来达到致病目的。
　　到现在为止，也没有证实有效的疫苗和医疗手段来防治埃博拉。虽然早有研究指出埃博拉的疫苗和一些药物在老鼠和猿猴等动物身上试验有效（比如，Zmapp），但是还没有zui终证据证实这些药物对人体确实有效。
　　病人在发现感染埃博拉病毒后，的方法是马上隔离，给患者以输液方式补充电解质以使患者尽量感觉舒服。然后，听天由命，超过一半的感染者zui终会死亡。
　　防疫措施：做好隔离
　　因为埃博拉病毒的zui终源头未明，所以科学家现在还没有得出野生动物感染埃博拉病毒的具体方式。而人类主要是通过身体接触而发生感染。这主要包括（1）接触感染者的血液，人体组织，埃博拉以及其它一些人体排泄物；（2）处理或者接触感染埃博拉病毒的动物的病体或者死体。虽然有证据表明动物之间可能会通过呼吸系统传染埃博拉病毒，但还没有证据支持人类通过呼吸系统互相传播埃博拉。
　　在非洲国家，能够接触埃博拉病毒感染者身体的方式主要包括：（1）参加埃博拉病毒死者的葬礼，并对尸体进行一些防腐处理；（2）循环使用埃博拉病毒患者的注射器和注射针（这在发达国家不成问题）；（3）医疗人员的不小心接触而爆发传染；（4）吃下病死的野生动物的肉。
　　埃博拉病毒一旦发现，的办法是对所有可能接触过埃博拉病毒患者的人员尽早进行隔离，并追踪所有接触过患者的人员。
　　从传染病学的角度，埃博拉病毒的高致死性以及不通过空气传播这两点，导致了埃博拉病毒的传染能力较弱。埃博拉病毒还来不及大规模扩散，其宿主已经死亡。这也是为什么埃博拉病毒爆发大半年才死亡不到1000人的原因。从这一点来看，只要做好隔离措施，埃博拉病毒并没有想象中的那么可怕。

美国NovaBios 埃博拉病毒IgG抗体检测试剂盒

我司还提供其它进口或国产试剂盒：登革热、疟疾、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的NovaBios产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

Diagnosis and treatment: where the difficulties come from
As the Ebola virus early onset and cold and other diseases are usually similar, making the health authorities prone to misdiagnosis, delaying the timely implementation of epidemic prevention measures.
Traditional diagnostic methods require complex laboratory tests (PCR and ELISA) to examine the presence of antigens in infected individuals. The latest technology can be used by patients with spittle and urine to check for the presence of Ebola virus. It is true that the Ebola virus needs a relatively long period of time, which further delays the epidemic prevention process. Which is why in December 2013 in Guinea outbreak of the epidemic, and by March 2014 before the final confirmation of the epidemic.
So far, scientists on the Ebola virus pathogenesis is not clear. It is generally believed that the Ebola virus by destroying the body's immune system, to prevent the body's adaptive immune system to achieve the role of pathogenic purposes.
Until now, there is no proven vaccine and medical means to control Ebola. Although it has long been pointed out that Ebola's vaccines and some drugs are effective in animals such as mice and apes (eg, Zmapp), there is no final evidence that these drugs are effective in the human body.
The patient is found to be infected with Ebola virus, the best way is to immediay isolate the patient to fill the electrolyte to make the patient as much as possible to feel comfortable. Then, resigned, more than half of the infected person will eventually die.
Epidemic prevention measures: do a good job isolation
Because the ultimate source of Ebola virus is unknown, so scientists have not yet come to the wild animals infected with Ebola virus specific way. While humans are infected by physical contact. This mainly includes (1) exposure to infected people's blood, human tissue, Ebola and other human excreta; (2) treatment or exposure to animals infected with Ebola virus or dead body. Although there is evidence that animals may spread between the Ebola virus through the respiratory system, but there is no evidence to support human transmission through the respiratory system Ebola.
In African countries, the way to access the Ebola virus's body mainly includes: (1) participation in the funeral of the Ebola virus deceased, and some of the corpse of the corpse treatment; (2) the use of Ebola virus patients syringe And the injection needle (which is not a problem in the developed countries); (3) medical personnel accidentally exposed to the outbreak of infection; (4) eat the dead animal meat.
Once the Ebola virus is found, the best way is to isolate all the people who may be exposed to Ebola virus and track all the patients who have been exposed to the patient.
From the perspective of infectious diseases, the high lethality of the Ebola virus and the lack of airborne transmission of these two points, resulting in the Ebola virus infection is weak. Ebola virus is too late to spread, its host has died. This is why the Ebola virus broke out more than half a year before the death of less than 1,000 reasons. From this point of view, as long as the isolation measures, Ebola virus and did not imagine so terrible.